A new urgency for collaboration is breathing new life into old concepts.
Utilization management (UM) processes transitioned from retrospective utilization review in the 1980s to prospective review in the 1990s. Because of the sentinel effect of early prospective programs, payers no longer review many services but do continue to manage high-cost services such as imaging and molecular diagnostics.
Also, payers and hospitals have continuously used evidence-based clinical criteria to help ensure unneeded or inefficient care is avoided. However, from the practitioners' point of view, UM means oversight of their medical practices as well as a drain on time and resources.
A more collaborative approach to UM changes the dynamic between payers and physicians and enables better, quicker processes. Automation can provide evidence-based decision support at the point of care for a range of services that includes acute care, procedures, imaging and specialty drugs.
Add access to medical policies and information about which providers are in-network for a particular patient at the time the physician and patient are making a decision, and you dramatically increase the power to influence quality and cost. Everyone wins: More consistent and better decisions improve outcomes, automated approval for most requests lowers the hassle factor for physicians, and an easy way to identify in-network providers lowers costs for payers and patients.
Another concept being revisited is bundling payment for episodes of care, the goal of which is to encourage care team coordination around evidence-based best practices and improve clinical and financial outcomes. Our industry has long discussed payment reform, agreeing that payment for value, not volume, is the desired goal. The question has been, with the complexity of interconnecting process and the need for buy-in from so many different stakeholders, how do you encourage effective care management through value-based reimbursement?
Early attempts to bundle payments for episodes of care were rife with problems. Manual processes were inefficient, preventing scalability and impact. Capitation without monitoring of quality, access and patient experience-call it "cap and run"-was the norm. Payers set goals, such as reducing the cost of a specific procedure by 5%, and providers were left to figure out how to meet them. There were no standards or technology to adjust risk or measure quality.
Here, too, automation and collaboration are driving progress. New technologies automate episode definitions and analytics that reflect 30 years of stakeholder agreement around quality metrics, reinforcing best practices and care coordination while addressing scalability issues. Together, these advances and a willingness-truly a need-to collaborate have helped bundled payment move light years beyond its early attempts, to the point where it is now viewed as one of the most promising payment reform strategies.
Which combination of approaches will prevail is not certain, but one thing is: Progress depends on all healthcare stakeholders working as an ensemble, supported by technology.
David K. Nace, MD, is vice president, medical director, for McKesson Corporation.
35th World AIDS Day Marks 20 Years of PEPFAR: Challenges and Strategies to Combat HIV/AIDS
November 29th 2023PEPFAR, having invested $100 billion and saved 25 million lives in the global fight against HIV/AIDS, faces Congressional hurdles in its reauthorization due to abortion debates. Despite widespread support and no evidence of abortion-related activities, the legislative process is at a standstill. Members of PEPFAR and authors of a recent editorial stress the significance of PEPFAR and advocate for integrating behavioral and social science into healthcare programs to achieve UNAIDS targets and address barriers in HIV/AIDS testing and treatment.
Read More
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen